Goldfinch Bio, Inc. — Form D
Goldfinch Bio, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2020-07-14. $69.7M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2020-07-14
- Form: D
- Accession: 0001693198-20-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Amount sold: $69.7M
- Investors: 26
- Date of first sale: 2020-06-29
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-370930
Issuer
- Name: Goldfinch Bio, Inc.
- CIK: 0001693198
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: 215 FIRST STREET, CAMBRIDGE, MA, 02142
- Phone: 617-585-2000
Officers, directors & promoters (16)
| Name | Role | Location |
|---|
| LOUIS BRENNER | Director | CAMBRIDGE, MA |
| ABBIE CELNIKER | Director | Mt. Arlington, NJ |
| Wen Chen | Director | New York, NY |
| Neil Exter | Director | Boston, MA |
| Joy Ghosh | Director | San Diego, CA |
| Anthony Johnson | Director | Dania, FL |
| FRANK MADDUX | Director | CAMBRIDGE, MA |
| FRANK CZERWIEC | Executive Officer | CAMBRIDGE, MA |
| CURTIS DEMICK | Executive Officer | CAMBRIDGE, MA |
| JEAN-CHRISTOPHE HARMANGE | Executive Officer | CAMBRIDGE, MA |
| Anthony Johnson | Executive Officer | Dania, FL |
| Kyle Kuvalanka | Executive Officer | Dartmouth, A5 |
| LORI RUDOLPH-OWEN | Executive Officer | CAMBRIDGE, MA |
| ABBIE CELNIKER | Executive Officer | Mt. Arlington, NJ |
| Neil Exter | Executive Officer | Boston, MA |
| PETER THOMSON | Executive Officer | CAMBRIDGE, MA |
Other filings by this issuer (1)
More